Find Academic Supervisors

Justin A. SitronView profile

Associate Professor

• Sexological Worldview
• Sexual Diversity
• Intercultural Sensitivity
• +5 more

Justin A. Sitron is an Associate Professor and Associate Dean at Widener University's College of Health and Human Services, specializing in Human Sexuality Studies. He holds a PhD in Human Sexuality (2008) from Widener, along with degrees in Education and Spanish from Villanova University. PhD, Human Sexuality (2008), Widener University BS, Education (2000), Villanova University BA, Spanish Language and Literature (1999), Villanova University As an educator, sexologist, and interculturalist, Sitron focuses on developing culturally sensitive curricula and training frameworks for sexuality education. His seminal work on the sexological worldview —a construct measuring professionals' cultural sensitivity to sexual diversity—has been published in leading journals. He integrates the Developmental Model of Intercultural Sensitivity (DMIS) into sexuality education, creating transformative learning experiences for graduate students. His research spans the intersection of cultural competence and sexual health, particularly in marginalized communities. Recent articles emphasize harm reduction in education, attitude measurement tools, and the evolution of sexological worldview frameworks. Sitron's work has been cited globally, influencing HIV education initiatives and LGBTQ+ inclusive practices. Outstanding Dissertation Award , Center for Education, Widener University (2008) Sitron is actively involved in professional organizations like AASECT and SSSS, serving as President of the latter since 2023. He advocates for critical thinking in graduate education and has been featured in Yahoo! Life , The Daily Item , and USA Today discussing topics such as asexuality, anal sex, and Pennsylvania sex education policies.

• Oncology
• HIV/AIDS and Cancer
• Medical Informatics
• +4 more

Roxanne Wadia, MD, holds dual roles as a Clinical Fellow in Pathology and Clinical Assistant Professor of Medicine (Medical Oncology) at Yale School of Medicine. Her expertise spans anatomic and cytopathology, with a focus on cancer diagnosis and treatment guidance. She completed her medical degree at Vanderbilt University School of Medicine (2008) and is board-certified in Anatomic Pathology (2023) and Cytopathology (2024). Dr. Wadia’s research integrates oncology, HIV/AIDS, and medical informatics, leveraging large datasets such as the VA’s Million Veterans Program to improve cancer care outcomes. She actively contributes to clinical care at Yale New Haven Hospital, the VA Connecticut Healthcare System, and the Hospital of Saint Raphael’s, emphasizing holistic patient care and interdisciplinary collaboration. Her research explores prostate cancer prognosis, HIV-related malignancies, and healthcare analytics. Key projects include developing predictive tools for nonmetastatic prostate cancer mortality and studying lung cancer surgery outcomes in HIV-positive patients. Dr. Wadia also mentors trainees in oncology and hematology, emphasizing independent clinical decision-making. She participates in the VA’s clinical training programs for medical students, residents, and fellows, fostering a balance between clinical practice and research innovation.

• Biomedical Informatics
• Health Informatics
• Artificial Intelligence
• +7 more

Zhe He is a Full Professor at Florida State University (FSU), leading the eHealth Lab in the School of Information (iSchool) within the College of Communication & Information. He holds courtesy appointments in the Department of Behavioral Sciences and Social Medicine (College of Medicine), Department of Computer Science, and Department of Statistics. His research focuses on biomedical informatics, AI, and big data analytics, aiming to improve population health and advance biomedical research through informatics applications. He directs the Institute for Successful Longevity and co-leads the Biostatistics, Informatics, and Research Design Program (BIRD) of the UF-FSU Clinical and Translational Science Award. Education: Postdoctoral training at Columbia University (2015), PhD in Computer Science from NJIT (2014), MS from Columbia University (2009), and BE from Beijing University of Posts and Telecommunications (2007). Research Interests: Clinical trial generalizability, ontology quality assurance, consumer health informatics, and AI in medicine. His work bridges biomedical terminologies, patient engagement, and healthcare equity, with a focus on older adults and underserved populations. Grants & Funding: Over $21.9M in grants from NIH (NLM, NIA, NIMH), AHRQ, Amazon, NVIDIA, and Eli Lilly. Active grants include projects on medical marijuana effects, AI-driven clinical training, HIV prevention, and lab result interpretation tools for older adults. Awards & Honors: 2022 Lois Lunin Award (ASIS&T), FAMIA (2022), two AMIA Distinguished Paper Awards, and recognition for interdisciplinary research. Promoted to Full Professor in 2025 after early tenure as Associate Professor (2020). Labs & Teams: Directs the eHealth Lab and collaborates with跨学科 teams in the OneFlorida Data Trust, UF-FSU Clinical and Translational Science Award, and the National Center for Biotechnology Information (during sabbatical).

• Medical Imaging
• Artificial Intelligence
• Machine Learning
• +7 more

Dr. Neal Bangerter is a Visiting Professor in the Department of Bioengineering at Imperial College London's Faculty of Engineering. He specializes in medical imaging (MRI), artificial intelligence, machine learning, and signal processing. Dr. Bangerter holds adjunct appointments at INSEAD, the University of Utah, and Brigham Young University. His research focuses on ultra-high field MRI, AI applications in healthcare, and data-driven bioscience technologies. He leads the London Collaborative Ultra-High Field Scanner (LOCUS) project and advises companies on AI and innovation strategies. Education: B.S. in Physics (UC Berkeley), M.S. and Ph.D. in Electrical Engineering (Stanford University). Career highlights include roles at McKinsey & Company, Microsoft, and Reactrix, as well as founding BYU's Medical Imaging Research Center. He has pioneered cross-faculty initiatives like the Crocker Innovation Fellowship Program. Research interests include novel MRI pulse sequences, AI in medical imaging, and large-scale health data analysis. His work spans collaborations with Stanford, Oxford, Cambridge, and Siemens Healthcare. He teaches executive education at INSEAD, focusing on bridging technical concepts with business strategies. Key awards include the David Evans Chair at Brigham Young University. His contributions to the UK Biobank Neuroimaging study and development of MRI techniques like RAFO-4 highlight his impact on advancing imaging technologies and AI applications in healthcare.

Lukas EngelmannView profile

Senior Lecturer

• History of Epidemiology
• History of Science and Medicine
• Digital Health
• +7 more

Lukas Engelmann is a Senior Lecturer at the University of Edinburgh , specifically within the Science, Technology and Innovation Studies department under the School of Social and Political Science . His research focuses on the history and sociology of biomedicine , with particular interest in epidemiological reasoning , visual cultures of disease , digital epidemiology , and decolonial approaches to medical history . The Epidemy Lab , which he founded, explores the historical development of epidemiology and its contemporary influence on data-driven public health and pandemic policy-making . Engelmann's work has been funded by prestigious grants including an ERC Starting Grant (2021-2025) for his research on the history of epidemiological reasoning, and support from the Wellcome Trust for projects examining the social dimensions of digital health . His book 'Mapping AIDS' (2018) established him as a leading scholar in medical visualization , while 'Sulphuric Utopias' (2020) with Christos Lynteris explores the technological history of maritime sanitation and its political implications. Recent publications emphasize the visual and data practices that have shaped epidemiology, including works on epidemic modeling during the COVID-19 pandemic , the history of plague mapping , and the ethical implications of digital phenotyping . He has also contributed to interdisciplinary discussions on syndemics , co-infection epistemology , and the commercialization of bacteriology in the early 20th century. His scientific contributions have earned recognition through editorial roles in journals like Big Data and Society , and collaborative projects such as 'Working with Diagrams' (2022) which investigates the epistemological role of visual tools in medical knowledge production. Scientific Awards and Funding: ERC Starting Grant (2021-2025) Wellcome Trust Institutional Support Fund British Academy/Leverhulme Small Research Grant Chancellor's Fellowship (University of Edinburgh) 'Sulphuric Utopias' listed in The Guardian's 30 Books to Understand the World (2020)

Doron BetelView profile

Assistant Professor

• Computational Genomics
• Bioinformatics
• Single-cell RNA-seq Analysis
• +3 more

Doron Betel serves as an Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences, with affiliations in both the Physiology, Biophysics & Systems Biology and Computational Biology programs. He directs the Applied Bioinformatics Core (ABC), a central service group providing specialized computational and analytical support for biomedical research across multiple institutions. Dr. Betel's research focuses on developing computational genomic tools for studying human diseases and cellular development, with emphasis on integrative analyses of genomic and epigenomic data from high-throughput assays. His work addresses specific questions related to disease progression, treatment response, stem cell differentiation, and neurological processes through two closely interacting research groups: the Applied Bioinformatics Core and his independent research lab. The analysis of his recent publications reveals a strong emphasis on single-cell and spatial genomics, cross-species data integration, and machine learning applications in cancer immunology and neurodegenerative disease modeling. His research spans multiple high-impact areas including cancer immunotherapy, stem cell biology, diabetes research, and cardiovascular regeneration, with numerous publications in top journals like Nature, Cell, and Nature Immunology. Through the Applied Bioinformatics Core, Dr. Betel provides extensive analytical support across various genomic platforms including single-cell RNA-seq, spatial transcriptomics, ChIP-seq, ATAC-seq, and variant calling. The Core serves as a vital resource for researchers at Weill Cornell Medicine and the broader Tri-Institutional network, offering specialized analysis, computational pipelines, and training services. Dr. Betel maintains extensive collaborations with leading researchers including Lorenz Studer at MSKCC for stem cell and neurodegenerative disease research, Tuomas Tammela for cancer genomics, and multiple immunology researchers studying T cell function in autoimmunity and cancer. His work bridges computational methodology development with direct biomedical applications across multiple disease areas.

Possu HuangView profile

Assistant Professor

• Protein Design
• Computational Biology
• Structural Biology
• +4 more

Possu Huang serves as Assistant Professor of Bioengineering in the Department of Bioengineering at Stanford University's School of Engineering. His research group operates from the Shriram Center for Bioengineering, sharing laboratory space with the Bintu Lab while maintaining an active interdisciplinary program bridging computational and experimental protein engineering. His educational journey includes: B.A. in Molecular and Cell Biology (Biochemistry) from UC Berkeley Ph.D. in Biochemistry and Molecular Biophysics from Caltech Postdoctoral training as Senior Fellow at University of Washington Dr. Huang's research focuses on atomic-precision protein design through integrated computational-experimental approaches. His lab has pioneered breakthroughs including the first computationally designed protein-protein interface, TIM barrel fold design principles, and the eOD HIV immunogen. Current work leverages machine learning , structural biology , and library optimization to develop therapeutic proteins and nanotechnology platforms, with particular emphasis on achieving natural-level complexity in engineered systems. Analysis of his 2023-2025 publications reveals three dominant trends: (1) generative AI for all-atom protein design (e.g., Protpardelle, SHAPES), (2) immunology applications targeting MHC complexes for HIV vaccine development, and (3) optogenetic tools through engineered fluorescent proteins. These works consistently integrate deep learning with wet-lab validation to solve biomedical challenges. Dr. Huang has mentored nine graduate students to completion, including PhD candidates Carla (defended June 2025), Christian (defended May 2025), and master's students Shankara and Kirsten. His lab maintains active social media presence (@possuhuanglab) and regularly publishes high-impact research while training the next generation of protein engineers. The Huang Lab operates as a dynamic interdisciplinary hub where computational biologists collaborate with experimentalists to push the boundaries of protein design. Current projects include developing tetravalent nanobody platforms, photoswitchable binders for temporal protein control, and AI-driven solutions for HIV immunogen design, all conducted within Stanford's state-of-the-art bioengineering facilities.

• Global Health
• Public Health
• Epidemiology
• +5 more

Mohsen Malekinejad is an Associate Professor at the University of California, San Francisco (UCSF) School of Medicine and serves as the director of the Center for Resilient Societies and Technology (CREST) . He is a core member of the RESILIENT network at the University of California system, focusing on pandemic intelligence and community resilience. His career spans 20 years of public health experience with expertise in evidence-based medicine, systematic reviews, and translating research into policy. Education: DrPH (UC Berkeley, 2008), MPH (UC Davis, 2003), MD (Tehran Azad University, 1999), Postdoctoral Studies (UCSF, 2009) Dr. Malekinejad's research addresses health disparities among marginalized populations globally, focusing on substance use disorders, HIV/HCV, and pandemic response strategies . His work includes methodological innovations for sampling hard-to-reach groups (e.g., homeless populations, drug users) and economic evaluations of public health interventions . Recent publications highlight systematic reviews on topics like COVID-19 exposure notification systems, TB testing cascades, and HIV risk behaviors . His methodological strengths include respondent-driven sampling, meta-analysis, and health equity frameworks. He has led major projects funded by NIH, CDC, and WHO, including the California Department of Public Health's COVID-19 Exposure Notification system implementation. Dr. Malekinejad also maintains an active role in graduate-level public health education and collaborates across disciplines to strengthen translational research.

Marla KellerView profile

Professor

• HIV Prevention in Women
• Vaginal Microbicides
• Pre-Exposure Prophylaxis (PrEP)
• +4 more

Dr. Marla Keller is a tenured Professor of Medicine and Obstetrics & Gynecology at Albert Einstein College of Medicine, currently serving as Executive Dean and holder of the Jacob and Jeanne Barkey Chair in Medicine. Director, NIH-funded Harold and Muriel Block Institute for Clinical and Translational Research Interim Senior Associate Dean for Clinical and Translational Research Vice Chair of Research for Department of Medicine Dr. Keller's research focuses on: Biomedical HIV prevention strategies Vaginal microbicide development PrEP implementation in women Cervical cancer screening in HIV+ women Immune responses to SARS-CoV-2 COVID-19 clinical trials Her recent publications emphasize: HPV infection and cervical precancer Vaginal microbiome interactions PrEP delivery systems HIV/HSV coinfection dynamics Convalescent plasma therapy Metronidazole treatment response Key scientific awards include: Infectious Disease Mentoring Award (2013) COVID-19 Distinguished Service Award (2021) Spirit of Achievement Changemaker Award (2023) New York Super Doctor (2011-2015)

• Health Policy and Systems Research
• Social Determinants of Health
• Participatory Action Research
• +9 more

Dr. Lucia D'Ambruoso is a Senior Lecturer at the Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen. She is based at the Aberdeen Centre for Health Data Science and leads international research on health systems, participatory methods, and verbal autopsy. She holds honorary and visiting positions at the University of the Witwatersrand (South Africa), Umeå University (Sweden), and Stellenbosch University, and serves on multiple international research and policy committees. PhD in Public Health, University of Aberdeen (2011) MSc in Public Health and Health Services Research, University of Aberdeen (2003) BSc (Hons) in Pharmacology, University of Aberdeen (1997) Her research focuses on health policy and systems, social determinants of health, and participatory action research, especially in sub-Saharan Africa and South Asia. She uses qualitative and mixed methods to understand how health systems can be made more equitable and responsive through community engagement, inter-sectoral action, and innovative data systems like verbal autopsy. Her recent publications demonstrate a strong focus on community-led health research, digital health platforms for emergency care, school-based mental health, and mortality data systems. She leads major NIHR and GCRF-funded programmes in South Africa and Rwanda, aiming to strengthen primary care and injury response systems through participatory methods. Scientific Awards: University of Aberdeen Interdisciplinary Research Award (2024) University of Aberdeen Outstanding Research Award (2024) Fellow, Stellenbosch Institute of Advanced Study (2025) Fellow, Royal Society for Public Health (2021) Fellow, Higher Education Academy (2017) Dr. D'Ambruoso teaches across global health, health policy, and research methods at both undergraduate and postgraduate levels. She supervises PhD students and is Deputy Director of the Centre for Global Development at the University of Aberdeen. She is actively involved in community engagement through NHS Grampian and serves on the editorial board of Global Health Action and the Steering Committee of the Politics of Health Group. Her research is supported by NIHR, MRC, Wellcome Trust, and international philanthropies. She leads the Verbal Autopsy with Participatory Action Research (VAPAR) initiative, which connects communities, researchers, and policymakers to generate actionable evidence on health equity. Her team works closely with the Agincourt HDSS in South Africa and has developed innovative tools for community health worker training and data collection.

Ram SamudralaView profile

Professor

• Bioinformatics
• Computational Biology
• Drug Discovery
• +10 more

Ram Samudrala is a Professor and Chief of the Division of Bioinformatics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences . His research focuses on multiscale computational biology , integrating protein structure prediction , drug discovery , and translational science to address medical challenges. He leads the development of the CANDO platform for therapeutic drug discovery and co-directs the Informatics Core at the Clinical and Translational Sciences Institute. PhD in Computational Biology (University of Maryland, 1997) BA in Computing Science and Genetics (Ohio Wesleyan University, 1993) Postdoctoral Fellowship in Protein Folding (Stanford University, 1997-2001) His work spans structural biology , genomics , and computational drug design , with applications in dentistry , infectious diseases , and cancer . He has received prestigious awards including the NIH Director's Pioneer Award (2010) and multiple Wiki Science Prizes . Samudrala's group collaborates globally, emphasizing in silico methods followed by in vitro and in vivo validation. Key grants include $1.22M NIH NCATS ASPIRE Reduction-to-Practice Award and $4.5M NIH/NLM BRIGHT Training Grant . 2023 Finalist, Clinical and Translational Sciences Institute Clinical Research Achievement Awards 2016 MacArthur Foundation 100&Change Top 50 2008 Alberta Heritage Foundation Visiting Scientist Award 2005 NSF CAREER Award He directs the BRIGHT Short-Term Training Program and serves on multiple editorial boards and review panels. Samudrala's group maintains a Protinfo web server for structural predictions and the Bioverse framework for systems-level analyses.

Andrew D. EatonView profile

Assistant Professor

• Social Work
• Health Disparities
• HIV/AIDS Research
• +8 more

Dr. Andrew D. Eaton is an Assistant Professor at the University of Regina’s Faculty of Social Work (Saskatoon Campus) and holds a Status-Only Assistant Professorship at the Factor-Inwentash Faculty of Social Work, University of Toronto. He earned his PhD and MSW from the University of Toronto and his BSW from Toronto Metropolitan University. His research focuses on HIV/AIDS, mental health crises, aging populations, sexual health, and harm reduction, with a commitment to community-based participatory research. Eaton’s work addresses complex comorbidities affecting marginalized groups, particularly sexual and gender minorities. He leads projects such as the '3 Infections, 1 Fight Study' using geospatial tools to reduce harm from injection drug use, and the 'ReportNeedles.ca' initiative to map needle disposal hotspots. His studies also explore cognitive remediation therapies for aging HIV-positive populations and crisis mental health response models. He holds grants from CIHR, SSHRC, CTN, and OHTN. His publications emphasize innovative interventions, including cognitive training programs, civilian-led crisis response systems, and global comparative studies on sexual identities. Eaton’s lab (eaton-lab.com) fosters collaboration between academics, practitioners, and communities to translate research into actionable health policies and practices.

Jerad MoxleyView profile

Assistant Professor

• Gerontology
• Psychology
• Mental Health
• +9 more

Jerad Moxley is an Assistant Professor of Psychology at Weill Cornell Medical College since 2022. His academic work bridges psychology and gerontology, focusing on mental health, cognitive functioning, and technology adoption in aging populations. He contributes to interdisciplinary research in medicine and public health, particularly in dementia care, palliative care, and aging with chronic conditions like HIV. Ph.D., Florida State University (2016) M.A., Murray State University (2008) B.A., Murray State University (2004) Dr. Moxley’s research explores the psychological and social dimensions of aging, including loneliness, pain disparities, and self-perceptions of aging. He investigates how technology can enhance aging in place and improve well-being for older adults with cognitive impairments or HIV. His work often integrates cross-cultural perspectives, as seen in studies on Puerto Rican older adults and racial/ethnic differences in pain and mental health outcomes. The trends in his publications highlight interdisciplinary approaches to aging, combining psychology, public health, and technology. Recent studies address elder neglect interventions, tech adoption barriers, and the role of social support in physical and cognitive health. Earlier work examines stress-cognition interactions, late-onset depression, and cognitive aging through chess skill and decision-making paradigms. Dr. Moxley has secured significant funding from the National Institute on Aging and the Administration for Community Living. Grants include projects on pain in later life, collaborative care models for serious illness, and technology-based interventions for aging adults with HIV. He serves as Co-Investigator and Key Personnel in initiatives like the CREATE Center and ENHANCE Center, focusing on aging and technology enhancement.

Alejandro Benjamin BalazsView profile

Assistant Professor

• Immunology
• Virology
• Molecular Biology
• +9 more

Alejandro Benjamin Balazs is an Assistant Professor of Medicine at the Ragon Institute of MGH, MIT, and Harvard. His laboratory specializes in synthetic immunology, gene transfer technologies, and immune system engineering to combat HIV and emerging viral threats like SARS-CoV-2. Current research focuses include: Understanding sterilizing immunity mechanisms against HIV. Studying pathogen escape from immunological pressure. Optimizing AAV vector delivery for broadly neutralizing antibodies. Investigating innate immune responses in viral neutralization. His lab has published extensively on: Antibody-mediated prophylaxis against HIV and SARS-CoV-2. Viral evolution and immune escape dynamics. AAV-based gene delivery systems. Humoral immunity in vulnerable populations. Immune signatures in humanized mouse models. Scientific accolades include: NIDA Avenir New Innovator (DP2) Grant (2015) Gilead Sciences Research Scholars Award (2016) MGH Transformative Research Scholars Award (2016) Doctoral students mentored in his lab include: Jackie Brady (Harvard BBS Program, 2015-2020) Allen Lin (Harvard Systems Biology, 2015-2020) Meredith Phelps (Harvard Virology, 2018-2022)

Silvi RouskinView profile

Assistant Professor

• RNA structure
• Gene regulation
• Alternative splicing
• +4 more

Dr. Silvi Rouskin serves as Assistant Professor in the Department of Microbiology at Harvard Medical School (Harvard University), where she leads groundbreaking research on RNA structural biology. Her work bridges computational biology, biochemistry, and single-molecule modeling to decode RNA's role in cellular processes and disease mechanisms. Her primary research focuses on RNA structure formation and its impact on gene regulation , alternative splicing , and viral pathogenesis . By pioneering tools like DMS-MaPseq and the DREEM algorithm, her lab detects multiple RNA conformations at single-nucleotide resolution in living cells. Current investigations target human, bacterial, and viral RNA structures to develop machine-learning prediction models for therapeutic applications in cancer and infectious diseases. Dr. Rouskin's publication record centers on RNA structural dynamics, exemplified by her 2020 HIV study revealing how alternative RNA configurations regulate viral gene activity. This work underpins her broader mission to build a comprehensive RNA structure database for accelerating drug target discovery. Her scientific accolades include: Pew Biomedical Scholar (2024) Vilcek Prize for Creative Promise in Biomedical Science (2021) Dr. Rouskin actively mentors the next generation of scientists, having guided at least one PhD candidate (Phil) to completion. Her lab currently supports undergraduate researchers including Tammy and Stuti (studying tau alternative splicing) and Sherry (investigating SMN1/SMN2 structures), reflecting her commitment to hands-on training in RNA biology. The Rouskin Lab operates at the Harvard Medical School campus (77 Avenue Louis Pasteur, NRB 930, Boston), combining wet-lab experimentation with computational innovation to advance structural RNA biology.